Jane Street’s Agios Pharmaceuticals AGIO Stock Holding History

Jane Street’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$18.3M	Sell	492,598 -192,642	-28%	-$5.84M	﹤0.01%	2231
2026 Q1	$23.2M	Sell	685,240 -435,810	-39%	-$12.4M	﹤0.01%	1647
2025 Q4	$30.5M	Buy	1,121,050 +725,930	+184%	+$25.5M	﹤0.01%	1249
2025 Q3	$15.9M	Buy	395,120 +361,631	+1,080%	+$13.6M	﹤0.01%	1879
2025 Q2	$1.11M	Sell	33,489 -92,615	-73%	-$2.81M	﹤0.01%	5407
2025 Q1	$3.69M	Sell	126,104 -87,923	-41%	-$2.92M	﹤0.01%	3384
2024 Q4	$7.03M	Buy	214,027 +87,522	+69%	+$4.11M	﹤0.01%	2254
2024 Q3	$5.62M	Sell	126,505 -50,310	-28%	-$2.28M	﹤0.01%	2669
2024 Q2	$7.62M	Buy	176,815 +52,280	+42%	+$1.89M	﹤0.01%	2361
2024 Q1	$3.64M	Buy	124,535 +26,514	+27%	+$710K	﹤0.01%	3102
2023 Q4	$2.18M	Buy	98,021 +42,996	+78%	+$964K	﹤0.01%	4163
2023 Q3	$1.36M	Sell	55,025 -14,595	-21%	-$386K	﹤0.01%	4692
2023 Q2	$1.97M	Buy	69,620 +44,049	+172%	+$1.1M	﹤0.01%	4186
2023 Q1	$587K	Sell	25,571 -4,145	-14%	-$110K	﹤0.01%	6053
2022 Q4	$834K	Buy	+29,716	New	+$837K	﹤0.01%	5257
2022 Q3	–	Sell	-50,479	Closed	-$1.35M	–	9614
2022 Q2	$1.12M	Buy	50,479 +42,841	+561%	+$968K	﹤0.01%	5282
2022 Q1	$222K	Sell	7,638 -60,461	-89%	-$1.85M	﹤0.01%	8886
2021 Q4	$2.24M	Buy	68,099 +954	+1%	+$38.4K	﹤0.01%	4251
2021 Q3	$3.1M	Buy	67,145 +36,170	+117%	+$1.75M	﹤0.01%	3587
2021 Q2	$1.71M	Sell	30,975 -28,938	-48%	-$1.62M	﹤0.01%	4653
2021 Q1	$3.09M	Buy	59,913 +13,746	+30%	+$681K	﹤0.01%	3182
2020 Q4	$2M	Sell	46,167 -15,789	-25%	-$624K	﹤0.01%	3484
2020 Q3	$2.17M	Buy	61,956 +50,739	+452%	+$2.22M	﹤0.01%	2908
2020 Q2	$600K	Buy	+11,217	New	+$519K	﹤0.01%	4793
2020 Q1	–	Sell	-15,358	Closed	-$710K	–	5237
2019 Q4	$733K	Buy	15,358 +2,287	+17%	+$86.4K	﹤0.01%	3196
2019 Q3	$424K	Buy	+13,071	New	+$541K	﹤0.01%	3746
2019 Q2	–	Sell	-5,578	Closed	-$376K	–	5069
2019 Q1	$376K	Buy	+5,578	New	+$325K	﹤0.01%	4005
2018 Q4	–	Sell	-17,813	Closed	-$1.37M	–	4856
2018 Q3	$1.37M	Buy	17,813 +13,761	+340%	+$1.11M	﹤0.01%	2364
2018 Q2	$341K	Buy	+4,052	New	+$353K	﹤0.01%	3991
2016 Q4	–	Sell	-19,327	Closed	-$1.02M	–	3975
2016 Q3	$1.02M	Buy	+19,327	New	+$842K	﹤0.01%	1928
2016 Q2	–	Sell	-8,746	Closed	-$355K	–	4009
2016 Q1	$355K	Buy	+8,746	New	+$374K	﹤0.01%	3018
2015 Q3	–	Sell	-2,661	Closed	-$296K	–	3511
2015 Q2	$296K	Buy	+2,661	New	+$287K	﹤0.01%	2835
2015 Q1	–	Sell	-10,692	Closed	-$1.2M	–	3077
2014 Q4	$1.2M	Buy	+10,692	New	+$955K	0.01%	911
2014 Q3	–	Sell	-13,933	Closed	-$638K	–	2492
2014 Q2	$638K	Buy	+13,933	New	+$568K	0.01%	1222
2013 Q4	–	Sell	-21,976	Closed	-$614K	–	2292
2013 Q3	$614K	Buy	+21,976	New	+$607K	0.01%	1560

Other funds holding AGIO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Jane Street's AGIO Position: Q2 2026 in Review

Jane Street reduced its Agios Pharmaceuticals (AGIO) stake by 28% in Q2 2026, selling an estimated $5.84M and leaving 492,598 shares worth $18.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2231.

Jane Street first reported a position in AGIO in Q3 2013 and has held it in 35 quarters since. The position peaked at $30.5M in Q4 2025. 239 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

Jane Street held 492,598 shares of Agios Pharmaceuticals worth $18.3M as of Q2 2026.
Jane Street sold 192,642 Agios Pharmaceuticals shares in Q2 2026, an estimated $5.84M.
Agios Pharmaceuticals made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #2231 holding.
Jane Street first reported a position in Agios Pharmaceuticals in Q3 2013 and has held it in 35 quarters since.
Jane Street's Agios Pharmaceuticals position peaked at $30.5M in Q4 2025.
239 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.